Antihypertensive drugs in COVID-19 infection

Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):415-416. doi: 10.1093/ehjcvp/pvaa058.

Authors

Sara-Joan Pinto-Sietsma¹, Michael Flossdorf², Veit R Buchholz², Joost Offerhaus¹, Hidde Bleijendaal¹, Martijn Beudel¹, Paul G A Volders³, Rachel M A Ter Bekke³, Tom Dormans⁴, Peter-Paul Zwetsloot⁵, Peter de Jager⁵, Steffen Massberg⁶, Patrick Rämer⁷, Clemens Wendtner⁷, Ellen Hoffmann⁸, Kathrin Rothe², Susanne Feihl⁹, Thorsten Kessler¹⁰, Yigal M Pinto¹, Heribert Schunkert¹⁰

Affiliations

¹ University of Amsterdam, Amsterdam, The Netherlands.
² Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Deutsches Zentrum für Infektionsforschung, München, Germany.
³ Maastricht University, Maastricht, The Netherlands.
⁴ Zuyderland Hospital, Heerlen, The Netherlands.
⁵ Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
⁶ Department of Cardiology. Klinikum der Ludwig-Maximilians-Universität and Deutsches Zentrum für Herz-Kreislauf-Forschung, München, Germany.
⁷ Department of Hospital Hygiene and infection prevention, Munich Municipal Hospital Group, München, Germany.
⁸ Department of Cardiology and Internal Intensive Care Medicine, Heart Center Munich-Bogenhausen, Munich Municipal Hospital Group, Englschalkinger Str. 77, Munich, Germany.
⁹ Klinikum Rechts der Isar, Technische Universität München, München, Germany.
¹⁰ Department of Cardiology, Technische Universität München, Deutsches Zentrum für Herz-Kreislauf-Forschung, Munich Heart Alliance; München, Germany.

No abstract available

Publication types

Comparative Study
Letter
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Adrenergic beta-Antagonists / administration & dosage
Angiotensin Receptor Antagonists / administration & dosage
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
Antihypertensive Agents / administration & dosage*
Antihypertensive Agents / adverse effects
COVID-19
Calcium Channel Blockers / administration & dosage
Coronavirus Infections / diagnosis
Coronavirus Infections / mortality
Coronavirus Infections / therapy*
Diuretics / administration & dosage
Drug Administration Schedule
Germany
Hospitalization
Humans
Hypertension / diagnosis
Hypertension / drug therapy*
Hypertension / mortality
Netherlands
Pandemics
Pneumonia, Viral / diagnosis
Pneumonia, Viral / mortality
Pneumonia, Viral / therapy*
Protective Factors
Risk Factors
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Calcium Channel Blockers
Diuretics